Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

A Novel Therapy for cocaine dependence during abstinence: A randomized clinical trial.

Pirnia B, Moradi AR, Pirnia K, Kolahi P, Roshan R.

Electron Physician. 2017 Jul 25;9(7):4862-4871. doi: 10.19082/4862. eCollection 2017 Jul.

2.

The Efficacy of Contingency Management on Cocaine Craving, using Prize-based Reinforcement of Abstinence in Cocaine Users.

Pirnia B, Tabatabaei SK, Tavallaii A, Soleimani AA, Pirnia K.

Electron Physician. 2016 Nov 25;8(11):3214-3221. doi: 10.19082/3214. eCollection 2016 Nov.

3.
4.

Psychosocial Interventions in Reducing Cannabis Use in Early Phase Psychosis: A Canadian Survey of Treatments Offered.

Aydin C, Tibbo PG, Ursuliak Z.

Can J Psychiatry. 2016 Jun;61(6):367-72. doi: 10.1177/0706743716639931. Epub 2016 Mar 16.

5.

Psychosocial interventions for cannabis use disorder.

Gates PJ, Sabioni P, Copeland J, Le Foll B, Gowing L.

Cochrane Database Syst Rev. 2016 May 5;(5):CD005336. doi: 10.1002/14651858.CD005336.pub4. Review.

6.

Contingency management for cocaine treatment: cash vs. vouchers.

Festinger DS, Dugosh KL, Kirby KC, Seymour BL.

J Subst Abuse Treat. 2014 Aug;47(2):168-74. doi: 10.1016/j.jsat.2014.03.001. Epub 2014 Mar 6.

7.

Effectiveness of financial incentives to improve adherence to maintenance treatment with antipsychotics: cluster randomised controlled trial.

Priebe S, Yeeles K, Bremner S, Lauber C, Eldridge S, Ashby D, David AS, O'Connell N, Forrest A, Burns T.

BMJ. 2013 Oct 7;347:f5847. doi: 10.1136/bmj.f5847.

8.

Relief of cannabis withdrawal symptoms and cannabis quitting strategies in people with schizophrenia.

Koola MM, Boggs DL, Kelly DL, Liu F, Linthicum JA, Turner HE, McMahon RP, Gorelick DA.

Psychiatry Res. 2013 Oct 30;209(3):273-8. doi: 10.1016/j.psychres.2013.07.044. Epub 2013 Aug 20.

9.

Duration effects in contingency management treatment of methamphetamine disorders.

Roll JM, Chudzynski J, Cameron JM, Howell DN, McPherson S.

Addict Behav. 2013 Sep;38(9):2455-62. doi: 10.1016/j.addbeh.2013.03.018. Epub 2013 Apr 3.

10.

A randomized study of contingency management in cocaine-dependent patients with severe and persistent mental health disorders.

Petry NM, Alessi SM, Rash CJ.

Drug Alcohol Depend. 2013 Jun 1;130(1-3):234-7. doi: 10.1016/j.drugalcdep.2012.10.017. Epub 2012 Nov 20.

11.

Cannabis withdrawal in chronic cannabis users with schizophrenia.

Boggs DL, Kelly DL, Liu F, Linthicum JA, Turner H, Schroeder JR, McMahon RP, Gorelick DA.

J Psychiatr Res. 2013 Feb;47(2):240-5. doi: 10.1016/j.jpsychires.2012.10.010. Epub 2012 Nov 10.

12.

Treatment of the depressed alcoholic patient.

DeVido JJ, Weiss RD.

Curr Psychiatry Rep. 2012 Dec;14(6):610-8. doi: 10.1007/s11920-012-0314-7. Review.

13.

State of the art treatments for cannabis dependence.

Danovitch I, Gorelick DA.

Psychiatr Clin North Am. 2012 Jun;35(2):309-26. doi: 10.1016/j.psc.2012.03.003. Epub 2012 Apr 10. Review.

14.

Using incentives to reduce substance use and other health risk behaviors among people with serious mental illness.

Tidey JW.

Prev Med. 2012 Nov;55 Suppl:S54-60. doi: 10.1016/j.ypmed.2011.11.010. Epub 2011 Dec 9. Review.

15.

Financial incentives to improve adherence to anti-psychotic maintenance medication in non-adherent patients - a cluster randomised controlled trial (FIAT).

Priebe S, Burton A, Ashby D, Ashcroft R, Burns T, David A, Eldridge S, Firn M, Knapp M, McCabe R.

BMC Psychiatry. 2009 Sep 28;9:61. doi: 10.1186/1471-244X-9-61.

16.

Examination of contingency payments to dually-diagnosed patients in a multi-faceted behavioral treatment.

Strong Kinnaman JE, Slade E, Bennett ME, Bellack AS.

Addict Behav. 2007 Jul;32(7):1480-5. Epub 2006 Nov 13.

17.

Regardless of psychiatric severity the addition of contingency management to standard treatment improves retention and drug use outcomes.

Weinstock J, Alessi SM, Petry NM.

Drug Alcohol Depend. 2007 Mar 16;87(2-3):288-96. Epub 2006 Sep 26.

18.

Millon Clinical Multiaxial Inventory-III subtypes of opioid dependence: validity and matching to behavioral therapies.

Ball SA, Nich C, Rounsaville BJ, Eagan D, Carroll KM.

J Consult Clin Psychol. 2004 Aug;72(4):698-711.

Supplemental Content

Support Center